Literature DB >> 8895580

Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development.

L Sun1, A Liu, K Georgopoulos.   

Abstract

The Ikaros gene, an essential regulator of lymphocyte differentiation, encodes, by means of differential splicing, protein isoforms with a distinct number of Kruppel-type zinc fingers organized in two domains. Deletion of the N-terminal zinc finger domain responsible for the sequence-specific DNA binding of the Ikaros proteins results in an early and complete arrest in lymphocyte development in homozygous mutant mice. In sharp contrast, heterozygotes reliably develop T cell leukemias and lymphomas. Here we show that the C-terminal zinc finger domain present in all of the Ikaros wild-type and mutant isoforms is responsible for their stable interactions off DNA and plays a pivotal role in determining their overall activity. Mutations in the C-terminal zinc fingers which ablate Ikaros protein interactions have a dramatic effect on the ability of these proteins to bind DNA and activate transcription. Therefore, interactions between Ikaros isoforms with an intact DNA binding domain are essential for their function. In contrast, interactions between isoforms with and without a DNA binding domain result in Ikaros complexes that do not bind DNA and, as a consequence, cannot activate transcription. Dominant-negative Ikaros isoforms are generated in smaller amounts by the wild-type Ikaros gene but are also produced exclusively by the N-terminally deleted Ikaros locus. Given these data, we propose that interactions between Ikaros isoforms are essential for normal progression through the lymphoid pathways. Mutations in the Ikaros gene that prevent Ikaros protein interactions or which change the relative ratio of DNA to non-DNA binding isoforms have profound effects in both lymphoid specification and homeostasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895580      PMCID: PMC452279     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

1.  The mutational specificity of DNA polymerase-beta during in vitro DNA synthesis. Production of frameshift, base substitution, and deletion mutations.

Authors:  T A Kunkel
Journal:  J Biol Chem       Date:  1985-05-10       Impact factor: 5.157

2.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.

Authors:  W K Cavenee; T P Dryja; R A Phillips; W F Benedict; R Godbout; B L Gallie; A L Murphree; L C Strong; R L White
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

Review 3.  Transcriptional activation: a complex puzzle with few easy pieces.

Authors:  R Tjian; T Maniatis
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Structural evidence for the authenticity of the human retinoblastoma gene.

Authors:  Y K Fung; A L Murphree; A T'Ang; J Qian; S H Hinrichs; W F Benedict
Journal:  Science       Date:  1987-06-26       Impact factor: 47.728

6.  The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse.

Authors:  A Molnár; P Wu; D A Largespada; A Vortkamp; S Scherer; N G Copeland; N A Jenkins; G Bruns; K Georgopoulos
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

7.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence.

Authors:  W H Lee; R Bookstein; F Hong; L J Young; J Y Shew; E Y Lee
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

8.  Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2.

Authors:  J Gyuris; E Golemis; H Chertkov; R Brent
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

9.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

10.  Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas.

Authors:  T P Dryja; J M Rapaport; J M Joyce; R A Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

View more
  114 in total

1.  Design of polyzinc finger peptides with structured linkers.

Authors:  M Moore; Y Choo; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation.

Authors:  P Sabbattini; M Lundgren; A Georgiou; C Chow ; G Warnes; N Dillon
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

3.  Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding.

Authors:  B S Cobb; S Morales-Alcelay; G Kleiger; K E Brown; A G Fisher; S T Smale
Journal:  Genes Dev       Date:  2000-09-01       Impact factor: 11.361

4.  Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes.

Authors:  J Koipally; A Renold; J Kim; K Georgopoulos
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

5.  DNase I footprinting of the human interleukin-5 gene promoter.

Authors:  D J Cousins; D Richards; D M Kemeny; S Romagnani; T H Lee; D Z Staynov
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 6.  Insights into T-cell development from studies using transgenic and knockout mice.

Authors:  M A Basson; R Zamoyska
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

7.  Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition.

Authors:  Pablo Gómez-del Arco; Kazushige Maki; Katia Georgopoulos
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

8.  Recombineering Hunchback identifies two conserved domains required to maintain neuroblast competence and specify early-born neuronal identity.

Authors:  Khoa D Tran; Michael R Miller; Chris Q Doe
Journal:  Development       Date:  2010-03-24       Impact factor: 6.868

9.  Ikaros promotes early-born neuronal fates in the cerebral cortex.

Authors:  Jessica M Alsiö; Basile Tarchini; Michel Cayouette; Frederick J Livesey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

10.  Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Authors:  Tawin Iempridee; Jessica A Reusch; Andrew Riching; Eric C Johannsen; Sinisa Dovat; Shannon C Kenney; Janet E Mertz
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.